发明名称 Inhibitors and methods of inhibiting bacterial and viral pathogens
摘要 Compounds, pharmaceutical compositions and methods for treating viral and bacterial infections, by administering certain thiourea compounds, specifically acylthiourea, carboximidoylthiourea and S-alkyl isothiourea derivatives and analogs, in therapeutically effective amounts are disclosed.
申请公布号 US9233087(B2) 申请公布日期 2016.01.12
申请号 US201113578413 申请日期 2011.02.18
申请人 SIGA TECHNOLOGIES, INC 发明人 Allen Robert D.;Amberg Sean M.;Dai Dongcheng;Burgeson James R.;Hruby Dennis E.
分类号 C07C335/26;C07C335/20;C07C335/38;C07D213/81;C07D213/82;A61K31/17;A61K45/06;C07D495/04;A61K31/4409 主分类号 C07C335/26
代理机构 Ostrolenk Faber LLP 代理人 Achkar Charles C.;Ostrolenk Faber LLP
主权项 1. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound having the following general Formula II or a pharmaceutically acceptable salt thereof: wherein X is selected from the group consisting of oxygen and NH; Y is selected from the group consisting of: —CH2—, —C(═O)—, —C(═S)— and —C(═NH)—; A is selected from the group consisting of: N and CR5; B is selected from the group consisting of: N and CR6; R1 is selected from the group consisting of: hydrogen and ethyl; R2 is selected from the group consisting of: hydrogen and chloro; R3 is selected from the group consisting of: hydrogen, methoxy, amino and hydroxyl; R4 is selected from the group consisting of: hydrogen, chloro and amino; R5 is selected from the group consisting of hydrogen and aminomethyl; and R6 is selected from the group consisting of hydrogen, amino and aminomethyl and wherein R3 and R4 cannot both be hydrogen.
地址 Corvallis OR US